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Summary
ONYX-015 is an adenovirus that lacks the E1B-55K gene product for p53 degradation. Thus, ONYX-015 was conceived as
an oncolytic virus that would selectively replicate in p53-defective tumor cells. Here we show that loss of E1B-55K leads
to the induction, but not the activation, of p53 in ONYX-015-infected primary cells. We use a novel adenovirus mutant,
ONYX-053, to demonstrate that loss of E1B-55K-mediated late viral RNA export, rather than p53 degradation, restricts
ONYX-015 replication in primary cells. In contrast, we show that tumor cells that support ONYX-015 replication provide
the RNA export function of E1B-55K. These data reveal that tumor cells have altered mechanisms for RNA export and
resolve the controversial role of p53 in governing ONYX-015 oncolytic selectivity.
Introduction tially tumorigenic lesions (Levine, 1997; Oren, 2003). Thus, inac-
tivation of the p53 tumor suppressor pathway is a critical event
There is a great need to identify therapies that trigger the rapid for tumorigenesis.
and specific death of tumor cells. Lytic viruses, whose replica- p53 was first identified through its interaction with a DNA
tion is tumor-selective, offer a novel and specific approach to viral protein, SV40 large T antigen (Lane and Crawford, 1979;
cancer therapy, with the potential to be self-perpetuating, kill Linzer and Levine, 1979). Like tumor cells, DNA viruses inacti-
tumors through regulated lytic death and spread not only within vate the p53 pathway, and many encode proteins that bind and
the tumor but also to distant micrometastases. dl1520/ONYX- degrade p53. Viral replication induces p53 due to expression
015 is the prototype for oncolytic adenoviral therapy (Khuri et of potent viral oncogenes, such as adenovirus E1A (Chiou and
al., 2000). It was originally conceived as an oncolytic virus that White, 1997; Lowe and Ruley, 1993), and/or the propagation of
would selectively replicate in tumor cells in which the p53 tumor double-stranded DNA viral genomes (Raj et al., 2001). Thus,
suppressor pathway is dysfunctional (Bischoff et al., 1996). viral proteins that inactivate p53 are thought to play a requisite
The p53 tumor suppressor pathway is inactivated in nearly role in viral replication by preventing p53-mediated cell cycle
all human tumors, either through direct mutation of p53 or the arrest or apoptosis. In adenovirus infection, E1B-55K appears
to fulfill this role, as together with E4-ORF6 and cellular proteinsloss of upstream regulators such as p14ARF or downstream p53
effectors such as Bax (Sherr and McCormick, 2002). DNA dam- involved in ubiquitination, it induces the degradation of p53
(Harada et al., 2002; Querido et al., 1997, 2001). ONYX-015age or activated oncogenes induce p53. which activates the
transcription of downstream p53 effectors, resulting in the cell (dl1520) is an adenovirus mutant that lacks the E1B-55K gene
and, therefore, fails to degrade p53 during viral replicationcycle arrest or apoptosis of cells that may have acquired poten-
S I G N I F I C A N C E
ONYX-015, a replication-competent oncolytic adenovirus, has entered the clinic and been found to be safe, with evidence of
promising tumoricidal activity. However, the role of p53 in governing ONYX-015 tumor selectivity has proved highly controversial.
Here we show that differential RNA export between normal and tumor cells is the major determinant of ONYX-015 oncolytic selectivity.
This reveals altered RNAexport in tumor cells as a novel and therapeutically exploitable target.We also demonstrate that in adenovirus
infection, loss of E1B-55K leads to the induction, without the activation, of p53, and consequently does not restrict ONYX-015 replication
in primary cells. This has important implications for understanding not only p53 inactivation, but also the design of novel p53-selective
oncolytic viruses.
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Figure 1. Nuclear p53 accumulates to high levels
in ONYX-015-infected primary cells
Quiescent primary small airway epithelium cells
(SAECs) were infected at a multiplicity of infec-
tion (moi) of 10 with E1A (dl312) control, WtD,
or ONYX-015 adenovirus.
A: At various hours postinfection (h.p.i.), lysates
were generated and examined for p53, various
early and late adenoviral proteins as indicated
(h  hexon, p  penton, f  fiber), and -actin
(loading control) expression by Western blotting.
B: Infected cells were fixed at 24 h.p.i. and ana-
lyzed for p53 and E1B-55K expression patterns by
immunofluorescence.
(Barker and Berk, 1987; Bischoff et al., 1996). On this basis, it RNA in the absence of E1B-55K, a propensity not shared by
primary cells. Thus, loss of E1B-55K-mediated late viral RNAwas predicted that ONYX-015would be restricted for replication
in normal cells, but would be capable of replicating in p53- export rather than p53 degradation is the major determinant of
ONYX-015 tumor-selective replication. These results providedeficient tumor cells. ONYX-015 has undergone extensive clini-
cal testing, with proven safety and evidence of promising clinical important new insights into the regulation of RNA export in
tumor versus normal cells and also suggest that adenovirus hasactivity from several indications (Khuri et al., 2000; Kirn, 2001;
Reid et al., 2002; Ries and Korn, 2002; Rudin et al., 2003). evolved a novel strategy for inactivating p53 in the absence of
E1B-55K.Moreover, biopsies from patients injected with ONYX-015 re-
vealed that the production of ONYX-015 viral particles is re-
stricted to tumor tissue and not observed in normal tissue that Results
had been injected adjacent to the tumor mass (Khuri et al.,
2000). ONYX-015 replication is defective in primary cells
Nevertheless, the precise role of p53 in determining ONYX- and induces high levels of nuclear p53
015 selectivity remains highly controversial (Goodrum and Or- To determine whether ONYX-015 replication is defective in pri-
nelles, 1998; Hall et al., 1998; Hann and Balmain, 2003; Harada mary cells in which the p53 pathway is intact, we measured
and Berk, 1999; McCormick, 2003; Nemunaitis et al., 2000; Ries replication in small airway epithelial cells (SAECs) and other low
et al., 2000; Rothmann et al., 1998; Turnell et al., 1999). This is passage human primary epithelial cells. ONYX-015 production
partly because ONYX-015 can replicate in several tumor cell was attenuated compared to wild-type virus in primary cells. A
lines that retain wild-type p53 sequences. However, this could nonreplicating control virus, E1A (Table 1), is a measure of
be attributed to the indirect inactivation of the p53 pathway in input in this assay. We next examined the kinetics of early and
tumor cells due to the loss of upstream regulators, such as late viral protein expression in ONYX-015- and wild-type virus-
p14ARF(Ries et al., 2000). More confounding has been the re- infected SAECs, as shown in Figure 1A. The onset of early viral
quirement for an E1B-55K late function for replication of ONYX- protein expression (E1B-19k, E2A, E4-ORF3, E4-ORF6, E4-ORF
015 in some tumor cell lines but not in others, irrespective of 6/7) in ONYX-015-infected SAECs closely paralleled that of wild-
their p53 status (Harada and Berk, 1999). Furthermore, it has type virus. In contrast, the onset and level of late protein expres-
sion (hexon, penton, fiber) was impaired in ONYX-015-infectedbeen proposed that p53 may even be required for productive
SAECs. There is a distinct lack of late protein expression inadenoviral replication (Hall et al., 1998).
ONYX-015-infected SAECs compared to WtD at 24 hours post-Thus, the poorly understood late functions of E1B-55K in
infection (h.p.i.), and ultimately a 3- to 5-fold reduction (as quan-viral replication, together with the difficulties of assessing p53
titated on a phosphorimager) in the levels of late proteins atfunction in tumor cells, have made the mechanism underlying
48 h.p.i., with hexon being the most severely affected. TheONYX-015 oncolytic selectivity difficult to determine. Here we
attenuation of ONYX-015 replication and late protein expressionresolve the role of p53 in determining ONYX-015 selectivity in
in normal cells correlated with the loss of E1B-55K-mediatedprimary epithelial cells where all components of the p53 pathway
p53 degradation, resulting in high levels of nuclear p53 (Figuresare intact. In addition, we use a novel adenovirusmutant, ONYX-
1A and 1B).053, to distinguish between the p53-dependent and -indepen-
dent functions of E1B-55K. We demonstrate that loss of E1B-
55K leads to the induction, but not the activation, of p53 in Accelerated S phase entry in normal cells infected
with ONYX-015ONYX-015-infected primary cells. Consequently, the replication
of ONYX-015 in primary cells is not restricted by p53. ONYX-015 One of the best-known effects of p53 induction is cell cycle
arrest. In adenovirus infection, the E1A viral protein activatestumor-selective replication appears to be instead determined by
a unique property of tumor cells to efficiently export late viral E2F and drives S phase entry. To determine whether p53 blocks
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Table 1. Restricted replication of ONYX-015 in primary human cells
Cell type Virus MOI dpi Total pfu Ratio WtD/015
SAEC-CI E1A 10 d2 6.07E  05
ONYX-015 10 d2 1.03E  06
WtD 10 d2 2.08E  07 20.2
E1A 10 d3 BLD
ONYX-015 10 d3 8.77E  05
WtD 10 d3 3.13E  07 35.7
HMEC-CI E1A 1 d3 BLD
ONYX-015 1 d3 3.34E  06
WtD 1 d3 2.81E  07 8.4
E1A 1 d7 BLD
ONYX-015 1 d7 5.17E  06
WtD 1 d7 6.83E  07 13.2
E1A 10 d3 BLD
ONYX-015 10 d3 2.29E  06
WtD 10 d3 1.61E  07 7.0
E1A 10 d7 2.11E  05
ONYX-015 10 d7 4.63E  06
WtD 10 d7 5.08E  07 11.0
HMEC-P E1A 1 d3 BLD
ONYX-015 1 d3 4.79E  06
WtD 1 d3 2.55E  08 53.2
E1A 1 d5 BLD
ONYX-015 1 d5 1.60E  07
WtD 1 d5 5.27E  08 32.9
E1A 10 d3 9.75E  04
ONYX-015 10 d3 3.60E  07
WtD 10 d3 1.90E  08 5.3
E1A 10 d5 4.73E  05
ONYX-015 10 d5 1.70E  08
WtD 10 d5 6.62E  08 3.9
Hepatocytes ONYX-015 10 d1 BLD
WtD 10 d1 BLD —
ONYX-015 10 d2 1.22E  05
WtD 10 d2 1.63E  07 133.6
ONYX-015 10 d4 5.67E  04
WtD 10 d4 4.41E  06 77.8
MOI, multiplicity of infection; dpi, days postinfection; pfu, plaque-forming units; SAEC, small airway epithelial cells; HMEC, human mammary epithelial cells;
CI, contact-inhibited; P, proliferating; BLD, below limit of detection.
this process in ONYX-015-infected normal cells, we examined were reached using an Acridine Orange/Ethidium Bromide
assay for apoptosis (data not shown). Consistent with this, inS phase entry at various times postinfection (Figures 2A and
2B). Unexpectedly, SAECs infected with ONYX-015 entered S ONYX-015 infection, p53 did not potentiate Caspase 3-medi-
ated apoptosis, as evidenced by similar levels of Caspase-3phase more efficiently than cells infected with wild-type adeno-
virus. This correlated with sustained higher levels of E1A in and PARP cleavage in ONYX-015 and wild-type virus infected
cells (Figure 3B). Furthermore, ZVAD, which inhibits caspaseONYX-015-infected cells (Figure 2C), and over a 10-fold in-
crease in viral genomes at 48 h.p.i. (Figure 2D) compared to activation, did not rescue ONYX-015 replication (Figure 3C),
although in the same cells it was sufficient to prevent TNF/wild-type virus-infected cells. We believe these effects are due
to the failure of ONYX-015 to shut down translation of early viral cycloheximide-mediated cell death (data not shown). Thus, p53-
mediated apoptosis does not account for the dramatic attenua-mRNAs, such as E1A, together with cellular RNAs, as shown
in Figure 5B. Nevertheless, it is of considerable interest that tion of ONYX-015 replication in normal cells. Based on this
evidence, we conclude that p53 does not attenuate ONYX-015ONYX-015 provokes entry into S phase despite the induction
of high levels of nuclear p53 in infected cells. replication by preventing S phase entry or significantly increas-
ing apoptosis.
p53 does not induce caspase-mediated apoptosis
in ONYX-015-infected primary cells p53 is induced, but not activated,
in ONYX-015-infected cellsp53 induction can also promote apoptosis. Therefore, we deter-
mined whether premature p53-dependent apoptosis accounted In ONYX-015-infected primary cells, supraphysiologically high
levels of p53 fail to provoke the expected biological effects,for the attenuation of ONYX-015 replication in normal cells.
However, despite extremely high levels of E1A and p53, there suggesting that p53 activity is blocked downstream. p53 is
thought to function primarily by inducing the transcription ofwas never more than a minor increase in apoptosis (at most an
8% increase in Annexin V/PI positive cells) in ONYX-015 versus downstream effectors (Chao et al., 2000; Jimenez et al., 2000;
Oren, 2003). Therefore, we examined two well-characterizedwild-type virus infected cells (Figure 3A). Similar conclusions
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Figure 2. Accelerated S phase entry in normal
cells infected with ONYX-015
Quiescent SAECs were infected with E1A, WtD,
or ONYX-015 at moi 10 and cell cycle parameters
examined at various h.p.i.
A:Cell cycle analysis was performed by quantify-
ing propidium iodide incorporation using a FACS
Calibur. The time point shown is at 24 h.p.i. and
is from a representative experiment.
B: The % change in S phase relative to t  0 is
plotted at various times postinfection.
C: Cell lysates were generated and examined
for expression of p53, Cyclin A, Cyclin B, and
-actin as well as Cdc2Y15 phosphorylation by
Western blot analysis.
D: DNA was isolated and viral genomes quanti-
fied by real-time Q-PCR as described in the
methods.
p53 downstream targets, p21 and Mdm2, in infected SAECs. together with an E1B-55K deletion (Figure 4C, right panel).
ONYX-101 is an adenovirus mutant which encodes only theSurprisingly, despite the induction of both p14ARF and high levels
of p53, neither p21 nor Mdm2 protein expression was induced E1A-p300 binding mutation. Like ONYX-015, ONYX-605 also
failed to activate p53-mediated transcription significantly. Thisduring ONYX-015 infection over that of control E1A-infected
cells (Figure 4A). In contrast, exposure of SAECs to ionizing suggests that the binding pf p300 to the amino terminus of E1A
does not account for the suppression of p53-directed transcrip-radiation induced both p53 and p21 in a dose-dependent man-
ner, confirming that these uninfected primary cells are fully com- tion in ONYX-015-infected primary cells.
petent for p53 function (Figure 4B). In addition to p21 andMdm2, One notable exception was Bax, a p53 target gene whose
p53 induces the transcription of several other downstream tar- mRNA levels increased significantly following ONYX-015 infec-
gets and effectors, including 14-3-3 , Cyclin G, GADD45, PIG-3, tion (Figure 4D). However, in ONYX-015-infected H1299 cells,
PERP, and Bax (Attardi et al., 2000; Oren, 2003; Yu et al., 1999). which are deficient for p53, Bax mRNA was induced to similar
We used real-time Q-PCR to directly determine whether the tran- levels and, thus, occurs due to loss of a p53-independent func-
scription of any of these p53 targets was induced in ONYX-015- tion of E1B-55K (Figure 4D, right panel). It is tempting to specu-
infected SAECs. Irradiated SAECs exhibited only a moderate late that Bax induction may account for the small increase in
induction of p53 protein levels compared to ONYX-015-infected apoptosis observed in ONYX-015-infected cells. However, we
SAECs. Nevertheless, we observed an appreciable induction of did not detect corresponding increases in Bax protein by West-
endogenous p53 transcriptional target genes in irradiated ern blotting (data not shown). We conclude that in ONYX-015-
SAECs (Figure 4C). Likewise, infection with a nonreplicating infected primary cells, nuclear p53 accumulates to supraphysio-
control virus also induced p53 transcriptional targets, presum- logically high levels, but does not induce the transcription of
ably through a DNA damage/stress response, triggered either downstream effectors and is thus unlikely to restrict ONYX-015
by viral DNA or the infection process itself. In contrast, despite replication.
the presence of extremely high levels of p53 in ONYX-015-
infected primary SAECs, downstream p53 transcriptional tar- ONYX-053 infection distinguishes between the p53-dependent
and -independent functions of E1B-55K for viral replicationgets were not induced. Similar results were also obtained in
ONYX-015-infected mammary epithelial cells (data not shown). in primary cells
These data suggest that the restriction of ONYX-015 replicationFurthermore, many p53 transcriptional targets decreased upon
ONYX-015 infection, analogous to wild-type virus infection in in normal cells is likely to be due to p53-independent functions
of E1B-55K, or, alternatively, novel functions of p53. The best-which p53 is degraded.
These data suggest that p53-mediated transcription can be characterized p53-independent function of E1B-55K is in medi-
ating the shutdown of host protein synthesis, which is thoughtinactivated independently of E1B-55K in an adenovirus infec-
tion. E1A binds and inactivates p300 (Chiou and White, 1997; to facilitate late viral protein production. To distinguish between
these possibilities, we analyzed the replication of a unique ade-Thomas and White, 1998), an important coactivator for p53-
mediated transcription and histone acetylation (Espinosa and novirus mutant, ONYX-053, in primary cells. This mutant ex-
presses a point mutant of E1B-55K (H260A) that fails to bindEmerson, 2001). Therefore, we examined an adenovirus mutant,
ONYX-605, which comprises an E1A-p300 binding mutation and degrade p53, yet retains all measurable late functions of
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As noted above, the best characterized functions of E1B-
55K, aside from p53 binding, relate to the shutoff of host protein
synthesis and the export of late viral RNAs (Babiss et al., 1985;
Leppard and Shenk, 1989; Pilder et al., 1986), which are thought
to be necessary for a productive viral infection. Therefore, we
determined the ability of ONYX-015 and ONYX-053 to shut off
host protein synthesis in primary cells. We measured host pro-
tein shutoff by determining S35 methionine incorporation into
cellular and viral proteins in infected cells (Figure 5B). Host
protein shutoff was observed at 36 h.p.i. in wild-type virus-
infected cells, consistent with its onset occurring post-DNA
replication. As expected,ONYX-015 failed to shut off the transla-
tion of host RNAs, whereas ONYX-053 mediated host protein
shutoff almost as efficiently as wild-type virus.
Defective late viral RNA export, not p53 induction,
restricts ONYX-015 replication in primary cells
E1B-55K is thought to mediate the switch from host to viral
protein synthesis by promoting the preferential export and trans-
lation of late viral RNAs, such as fiber and hexon. Consistent
with this, we had observed over a 3- to 5-fold defect in the
levels of fiber and hexon protein expression in ONYX-015-
infected SAECs compared to WtD (Figure 1A). To determine
whether this correlated with a defect in late viral RNA export in
the absence of E1B-55K, we examined the cytoplasmic/nuclear
ratios of spliced fiber RNA by real-time Q-PCR in ONYX-
15- andWtD-infected SAECs (Figure 6A). There was a 3- to 4-fold
defect in the cytoplasmic/nuclear ratio of fiber RNA in ONYX-
015-infected SAECs compared to WtD, consistent with the de-
fect observed in late viral protein expression.
Nevertheless, real-time Q-PCR quantitates the levels of the
gene of interest relative to an endogenous gene, in this case
Figure 3. p53 does not induce caspase-mediated apoptosis in ONYX-015-
18s rRNA, that is presumed to remain constant within the assay.infected primary cells
However, it assumes that both ONYX-015 and WtD infectionQuiescent SAECs were infected with E1A (gray bar), WtD (white bar), or
have similar effects on endogenous cellular RNA export, andONYX-015 (black bar) at moi 10 and apoptotic parameters examined at
various h.p.i. A: Apoptotic extent was determined by quantifying Annexin moreover, that different cell types (for example, tumor versus
V/PI staining. The % of cells positive for Annexin V/PI is depicted. The data normal) are comparable in their export of endogenous cellular
and standard deviation resulting from the average of three independent RNAs. Therefore, we developed an RNA fluorescent in situ hy-
experiments is plotted.
bridization (FISH) assay, which obviates the necessity of normal-B: Cell lysates were generated and analyzed for Caspase 3 and PARP
ization relative to endogenous RNAs, to determine unequivo-cleavage (indicated by lower arrow) by Western blotting.
C: The effect of the caspase inhibitor, ZVAD, on viral production was deter- cally if ONYX-015-infected normal cells are defective for the
mined and the time point shown represents the average from two indepen- export of late viral mRNAs in the absence of E1B-55K. The fiber
dent measures, each at 48 h.p.i. Standard deviation is represented. The
and hexon RNA FISH probes selectively detect late viral RNAsconcentrations of ZVAD used were sufficient to inhibit TNF/cycloheximide-
and not viral DNA (Supplemental Figures S1A and S1B at http://induced apoptosis in the same cells.
www.cancercell.org/cgi/content/full/6/6/611/DC1/). RNA FISH
confirmed our real-time Q-PCR analysis and demonstrated that
the export of fiber (Figure 6A) and hexon (Figure 6B) RNA is
defective in ONYX-015-infected SAECs compared to bothE1B-55K for viral replication (Shen et al., 2001). Two other E1B-
ONYX-053 and wild-type virus. Clearly, late viral RNAs do enter55K viral mutants, ONYX-051 and ONYX-052, were also de-
the cytoplasm in ONYX-015-infected cells, as evidenced byscribed as having such properties in tumor cell lines (Shen et
cytoplasmic staining in a percentage of ONYX-015-infectedal., 2001). However, in primary cells, these viruses induced p53
cells (Figures 6A and 6B, toppanel), and late viral protein expres-degradation (data not shown), suggesting that the ability of
sion in Figure 1A, albeit delayed and at lower levels. Basedthese E1B-55K point mutants to bind p53 may be affected by
on this evidence, we conclude that there is a defect in thetumor-specificmodifications. Figure 5A shows that primary cells
accumulation of late viral RNAs in the cytoplasm of ONYX-015-infectedwithONYX-053, likeONYX-015, accumulate high levels
of p53. Similar to ONYX-015, high levels of p53 in ONYX-053- infected primary cells.
Thesedata also allowus to visualize by immunofluorescenceinfected cells also failed to induce downstream p53 transcrip-
tional targets (Figure 4C), again with the exception of Bax (Figure the direct role of E1B-55K in the transport of late viral RNAs.
In cells infected with wild-type adenovirus, E1B-55K (red) was4D). Thus, both ONYX-015- and ONYX-053-infected SAECs
accumulate high levels of p53 due to loss of E1B-55K-mediated nuclear, but localized to the cytoplasm coincident with hexon
and fiber RNAs (Figures 6A and 6B, lower panels). Consistentp53 degradation.
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Figure 4. Despite supraphysiologically high levels
of p53 in ONYX-015-infected primary cells, down-
stream p53 transcriptional targets are not in-
duced
A: Quiescent SAECs were infected with E1A,
WtD, or ONYX-015 at moi 10 and examined at
various h.p.i. for p53, p14ARF, p21, Mdm2, and
-actin expression by Western blot analysis.
B: SAECs were analyzed at various time points
following treatment with increasing doses of 
radiation for p53, p21, and -actin expression by
Western blotting.
C: The induction of p53 transcriptional targets in
SAECs that had either been irradiated with 8 Gy
of  radiation or infected with E1A, WtD, ONYX-
015, ONYX-053, ONYX-101, or ONYX-605 adenovi-
rus was determined at various time points by real-
time Q-PCR. The fold induction of mRNAs relative
to t 0 is shown. cDNAs were normalized relative
to either 18S or GUS expression with similar con-
clusions; GUS data is plotted. p53 protein levels
were determined in the same experiment by
Western blot analysis.
D: The induction of Bax mRNA in infected SAECs
and H1299 tumor cells (moi 10) was determined
at various h.p.i. by real-time Q-PCR. The fold in-
duction relative to t  0 at 24 (gray and white
bars) and 36 (black bar) h.p.i. in each cell type
is plotted.
with the failure of ONYX-053 to degrade p53 during infection, with the loss of p53 degradation and cytoplasmic localization
of E1B-55K. While ONYX-053 is not completely wild-type forE1B-55Kwas localized predominantly in the cytoplasm and also
did not colocalize with hexon RNA in the nucleus (Figures 6A host protein shutoff, our data suggest that neither nuclear reten-
tion nor robust E4-ORF6 binding is absolutely required for trans-and 6B, middle panel). A striking transition of fiber RNA from a
diffuse nuclear pattern to the nuclear edge was also observed port of late viral RNAs by E1B-55K, and that E4-ORF6 may act
independently of E1B-55K to regulate late viral protein expres-on export of viral RNAs (Figure 6A). E1B-55K is a shuttle protein
that is retained in the nucleus by E4-ORF6 (Goodrum et al., sion. Alternatively, E1B-55K and E4-ORF6 may still depend on
each other to mediate different aspects of late viral RNA export,1996; Kratzer et al., 2000; Orlando and Ornelles, 2002), and
with which it forms a complex to degrade p53 (Harada et al., although their colocalization may not be required.
To determine whether p53 accumulation or defects in host2002; Querido et al., 1997, 2001). Thus, adenoviral mutants
lacking E4-ORF6 also fail to degrade p53. An E1B-55K/E4- protein shut-off/RNA export were responsible for the attenua-
tion of ONYX-015 in normal cells, we compared ONYX-053 andORF6 complex is thought to be necessary for late viral RNA
export, since late viral RNA export and protein expression have ONYX-015 replication in primary cells. Remarkably, despite the
failure to degrade p53, ONYX-053 replication was only attenuatedbeen reported to be defective in cells infected with E4-ORF6
adenoviral mutants (Cutt et al., 1987; Gonzalez and Flint, 2002; 2- to 3-fold compared to wild-type virus (Figure 6C). In contrast,
ONYX-015 replication was attenuated 13- to 25-fold in the sameGoodrum and Ornelles, 1999; Halbert et al., 1985). The E1B-
55K mutant expressed by ONYX-053 is severely compromised cells. The 2- to 3-fold reduction in ONYX-053 replication com-
pared to wild-type virus may reflect a novel function of p53 inin its ability to bind to E4-ORF6 (Shen et al., 2001), consistent
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by providing the late functions of E1B-55K. To test this predic-
tion, we examined late viral RNA export in HCT-116 cells in-
fected with ONYX-015 and wild-type virus (Figure 7A). Even in
the absence of E1B-55K, fiber RNA is exported efficiently to
the cytoplasm in ONYX-015-infected HCT-116 cells analogous
to a wild-type virus infection. Similar results were obtained in
infected MDA-MB-361 breast tumor cells that are also permis-
sive for ONYX-015 replication (Supplemental Figures S2A and
S2B). We next examined host protein shutoff in HCT-116 cells
infected with ONYX-015 or wild-type virus. Figure 7B demon-
strates that there is a shutdown in cellular but not viral protein
synthesis in ONYX-015-infected HCT-116 cells despite the ab-
sence of E1B-55K. Consistent with this, and in contrast to pri-
mary cells, there was no delay in the onset or level of late viral
protein expression in ONYX-015-infected HCT-116 cells (Figure
7C). This is a general property of tumor cells that support ONYX-
015 replication (Supplemental Figure S3).
The mechanism by which tumor cells shut down the synthe-
sis of cellular proteins is of considerable interest. Such a capabil-
ity would be of no obvious benefit to tumor cell proliferation or
survival. In adenovirus infection, expression of the late viral 100K
protein inhibits the translation of capped cellular mRNAs, while
viral RNAs are translated in a cap-independent manner due to
their possession of a unique 5 UTR (Cuesta et al., 2000; Hayes
et al., 1990). Consistent with this, 100K mutant viruses are de-
fective for host protein shutoff and replication (Hayes et al.,Figure 5. ONYX-053 uncouples the functions of E1B-55K in p53 degradation
and host protein shutoff in infected primary cells 1990; Morin and Boulanger, 1986). In Figure 7Dwe demonstrate
that, in addition to fiber RNA, 100K RNA export is also defectiveQuiescent SAECs were infected with E1A, ONYX-015, ONYX-053, or WtD
adenovirus at moi 10. in ONYX-015-infected SAECS. Therefore, it will be interesting
A: Lysates were generated at various h.p.i. and examined for p53 and E1B- to determine if the shutoff of host protein synthesis in permissive
55K expression patterns by Western blotting.
tumor cells is a secondary consequence of their ability to exportB: Infected cells were starved in cysteine/methionine-free media at 24 and
late 100K RNA. Figure 7D also demonstrates that permissive36 h.p.i. for 1 hr and then labeled with 35S-Met for 1 hr. Normalized protein
lysates were separated by gel electrophoresis and analyzed on a STORM tumor cells, such as HCT-116 and MDA-MB-361, export late
phosphorimager. viral RNAs 5–10 times more efficiently than primary cells upon
ONYX-015 infection, and selectively complement the loss of
E1B-55K in viral replication. Consequently, and in contrast to
primary cells, the percentage of late viral RNA in the cytoplasm
of ONYX-015-infected tumor cells is approximately equivalentattenuating ONYX-015 replication in primary cells. Indeed, a
to that of wild-type virus. Based on this evidence, we conclude
similar reduction in ONYX-015 replication was observed in HCT-
that the tumor-selective replication of ONYX-015 is determined
116 tumor cells when p14ARF expression and p53 were restored by a novel and unprecedented difference between tumor and
(Ries and Korn, 2002). Alternatively, the small reduction in normal cells for the export of late viral RNAs, as depicted in
ONYX-053 replication in normal cells may reflect the mild defect Figure 7D.
in host protein shutoff in ONYX-053 versus wild-type virus in-
fected cells (Figure 5B). Nevertheless, we conclude that the Discussion
major mechanism underlying the failure of ONYX-015 to repli-
cate in normal cells is the defective export of late viral RNAs ONYX-015 was originally conceived as a virus whose replication
and/or defective host protein shutoff. would be restricted to tumor cells that had inactivated p53.
Consistent with this, ONYX-015 was shown to be safe and
Permissive tumor cells provide the late viral RNA export undergo tumor-selective replication in Phase I and II clinical
functions of E1B-55K trials (Khuri et al., 2000; Kirn, 2001; Reid et al., 2002; Ries and
These results indicate that ONYX-015 fails to replicate in normal Korn, 2002; Rudin et al., 2003). However, patient responses did
cells primarily due to the loss of E1B-55K functions unrelated not necessarily correlate with the p53 status of their tumors
to p53 degradation. This implies that the tumor selectivity of (Khuri et al., 2000), and indeed in cell culture, ONYX-015 was
ONYX-015 is also likely to be determined by the same function shown to replicate in several tumor cell lines that retain wild-
of E1B-55K. Previous studies have indicated that cytoplasmic type p53 sequences (Goodrum and Ornelles, 1998; Harada and
fiber and hexon RNAs correlate with tumor cell permissivity to Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999). One
ONYX-015 (Goodrum and Ornelles, 1998, 1999; Harada and interpretation of this data is that a p53-independent mechanism
Berk, 1999). Thus, we predicted that tumor cells that support determined ONYX-015 selectivity in tumor cells. An alternative
ONYX-015 replication to wild-type virus levels, such as HCT- explanation is that the p53 pathway is indirectly inactivated in
these tumor cells through loss of p14ARF, p53-responsive cell116 cells (Harada and Berk, 1999; Ries and Korn, 2002), do so
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Figure 6. Loss of E1B-55K-mediated late viral RNA
export, rather than p53 degradation, is the major
limitation for ONYX-015 replication in primary
cells
A: Quiescent SAECs were infected with ONYX-
015 or WtD at moi 10. Nuclear and cytoplasmic
RNA were isolated at 24 and 36 h.p.i. and exam-
ined by real-time Q-PCR for the levels of spliced
L5-fiber mRNA. The relative level of L5-fiber mRNA
was determined as a % of 18S rRNA within the
same samples. The cytoplasmic/nuclear ratio of
fiber mRNA is plotted; standard error is repre-
sented.
B and C: SAECs infected with ONYX-015, ONYX-
053, or WtD at moi 10 were fixed at 48 h.p.i.,
and fluorescent in situ hybridization (FISH) was
performed with either an anti-sense digoxigenin-
labeled fiber (B) or hexon (C) RNA probe. Fiber
and hexon RNAs were each detected using a
FITC anti-digoxigenin-labeled secondary anti-
body. Cells were costained with mouse anti-E1B-
55K, which was detected using an Alexa-532
anti-mouse antibody. Nuclei were counter-
stained with Hoescht and images acquired on
a Zeiss Meta-Scanning Confocal Microscope.
E1A infected cells showed only background
staining for E1B-55K as well as fiber and hexon
RNA. The specificity of the FISH probes for fiber
and hexon RNAs, and not viral DNA, was con-
firmed by the failure to detect appreciable stain-
ing with either the digoxigenin-labeled fiber or
hexon RNA probes to the coding strand in the
same experiment.
D: Virus production in quiescent SAECs infected
with ONYX-015, ONYX-053, or WtD virus at moi 10
was determined at 52 and 72 h.p.i. A representa-
tive experiment that was measured in triplicate
is shown.
cycle/apoptosis checkpoints, or novel components of the p53 largely irrelevant for ONYX-015 replication, a novel or unknown
function of p53 in limiting viral replication could not be excluded.pathway (Ries et al., 2000).
Due to the caveats of assessing p53 function in tumor cells For example, p53 has recently been shown to have transcrip-
tionally independent effects in promoting apoptosis throughin which the p53 pathway is generally defective, we chose in-
stead to study ONYX-015 replication in primary epithelial cells localization to the mitochondria (Chipuk et al., 2004; Mihara
et al., 2003). Notwithstanding, our use of a novel adenovirusin which all components of the p53 pathway are intact. We
demonstrate that, although nuclear p53 accumulates to high expressing an E1B-55K pointmutant, ONYX-053, demonstrates
that the major defect in ONYX-015 replication in primary cellslevels in ONYX-015-infected primary cells, it is biologically inert.
While these data strongly suggested that p53 is, therefore, is due to the loss of E1B-55K late functions unrelated to p53,
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Figure 7. Tumor cells permissive for ONYX-015
replication provide the late viral RNA export/host
protein shutoff function of E1B-55K
HCT-116 cells were infected with E1A, ONYX-
015 or WtD at moi 30 and analyzed for late viral
RNA export (A), host protein shutoff (B), and late
viral protein production (C).
A: Infected cells were fixed at 24 h.p.i. and RNA
FISH performed with a digoxigenin-labeled fiber
RNA probe. Fiber RNA was detected using a Rho-
damine anti-digoxigenin-labeled secondary an-
tibody. Nuclei were counterstained with Hoescht
and images acquired on a Zeiss Meta-Scanning
Confocal Microscope.
B: Infected cells were starved at 24 h.p.i. in cyste-
ine/methionine-free media for 1 hr and then la-
beled with 35S-Met for 1 hr. Normalized protein
lysates were separated by gel electrophoresis
and analyzed on a STORM phosphorimager.
C: Lysates were generated from infected cells
at various h.p.i. and analyzed for E1A and late
protein expression (h  hexon, p  penton, f 
fiber) by Western blotting.
D and E: Quiescent SAECs, HCT-116, or MDA-MB-
361 tumor cells were infected with either ONYX-
015 or WtD. Nuclear and cytoplasmic RNA were
isolated at various h.p.i. and examined by real-
time Q-PCR for the levels of spliced L5-fiber and
spliced L4-100K mRNAs. The relative level of L5-
fiber and L4-100K mRNA was determined as a %
of 18s rRNA expression within the same samples.
The cytoplasmic/nuclear ratio of fiber and 100K
RNA is plotted for ONYX-015-infected samples at
36 h.p.i.
E: The % of fiber or 100K RNA within the cytoplasm
is expressed as a percentage of the total cyto-
plasmic and nuclear levels for each message
from either ONYX-015 or WtD infected SAECs
(gray bar), HCT-116 (white bar), or MDA-MB-361
(black bar) cells at 36 h.p.i. In each case, stan-
dard error is depicted.
F: Although p53 accumulates to high levels in
ONYX-015-infected primary cells, it is biologically
inert and thus largely irrelevant for replication.
The tumor-selective replication of ONYX-015 is
instead determined by a tumor cell’s property
to rescue the export and expression of late viral
RNAs (which are required for the production of
infectious virions) in the absence of E1B-55K.
although obviously it is impossible to exclude a function for p53 more, at least one late protein, 100K, playsmultiple roles in virus
production. 100K is necessary for the shutoff of host proteinin vivo. Furthermore, we show that tumor cells that support
ONYX-015 replication provide the function of E1B-55K in late synthesis and late viral RNA translation (Cuesta et al., 2000;
Hayes et al., 1990; Huang and Schneider, 1991) and plays aviral RNA export. Based on this evidence, we conclude that the
major determinant of ONYX-015 tumor selectivity is RNA export. critical role in the morphogenesis and assembly of virion parti-
cles (Cepko and Sharp, 1982; Morin and Boulanger, 1986). InThe assembly of replication-competent viral particles de-
pends upon the association of many late viral proteins and is addition, 100K is particularly required for hexon protein expres-
sion (Farley et al., 2004), which is one of the late proteins thatdriven by a process of mass action. Therefore, changes in the
concentration of multiple late viral proteins are expected to have is most affected by the loss of E1B-55K in ONYX-015-infected
SAECS. We demonstrate that loss of E1B-55K also results inamplified effects on assembly. This is likely to account, in part,
for how a 2- to 4-fold defect in the export and expression of a defect in 100K RNA export which could impact the production
and assembly of infectious virions at multiple levels. Thus, weseveral late viral RNAs, such as hexon and fiber, could result
in up to a 25-fold reduction in infectious viral particles. Further- favor the hypothesis that it is the cumulative defect in the export
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and expression of several late viral RNAs, rather than any single their cap-independent translation (Yueh and Schneider, 1996)
as well as playing a role in their export (Huang and Flint, 1998).RNA, that accounts for the defect in ONYX-015 replication in
primary cells. We are currently investigating whether cellular RNAs containing
5 UTRs that are structurally related to the late adenoviral 5The loss of E1B-55K-mediated p53 degradation in ONYX-
015-infected primary cells was expected to activate a p53 UTR are preferentially exported in tumor cells. Interestingly,
increased replication of ONYX-015 in tumor cells has previouslycheckpoint that would limit viral replication. However, while both
ONYX-015 and ONYX-053 induce high levels of nuclear p53 in been shown to correlate with S phase, as tumor cells vary in
the extent towhich they rescueONYX-015 replication (Goodruminfected cells, this did not result in inhibitory biological effects
on viral replication. One interpretation of these results is that and Ornelles, 1999). Therefore, the property of tumor cells to
export late viral RNAs may be a result or function of deregulatedinactivation of p53may not be required for adenoviral replication
after all. However, disparate DNA viruses have functionally con- proliferation, as even proliferating normal cells do not support
ONYX-015 replication (Table 1 and Johnson et al., 2002). Possi-verged to evolve proteins that inactivate p53; for example, HPV
degrades p53 through the early viral protein E6, while SV40 ble insights into the mechanism of late viral RNA export in
tumor cells may be derived from how E1B-55K functions in thisLarge T binds and inactivates p53 directly. Thus, a more plausi-
ble explanation is that adenovirus possesses yet another strat- process. While differential RNA splicing has been suggested in
tumor cells (Bartel et al., 2002), alterations in RNA export remainegy that inactivates p53 in the absence of E1B-55K. The adeno-
viral proteins E1A and E1B-19K promote cell-cycle entry and unknown. Interestingly, NUP88 and NUP214, two nuclear pore
prevent apoptosis (Debbas andWhite, 1993; White et al., 1991), proteins implicated in RNA export, have been found as translo-
respectively; these functions could perhaps override the effects cation products in myeloid leukemia (Arai et al., 1997; Boer et
of p53-induced downstream effectors on cell cycle entry or al., 1998; Nakamura et al., 1996). However, the contributions
apoptosis in ONYX-015-infected cells. However, the failure of of thesemutations to tumorigenesis still remain to be elucidated,
p53 to even induce the transcription of such downstream ef- as the regulation and mechanics underlying normal mammalian
fectors in ONYX-015-infected cells suggests that p53 is inacti- RNA export are poorly understood. Nonetheless, the revelation
vated more directly. One candidate for such a role is E4-ORF6, that late viral RNA export is the major determinant of ONYX-
the binding partner of E1B-55K, which is also known to interact 015 tumor selectivity provides an important insight and impetus
with p53 (Dobner et al., 1996). An alternative candidate is E1A, for the study of RNA transport in tumorigenesis as well as for
which binds and inactivates p300 (Chiou and White, 1997; cancer therapy.
Thomas and White, 1998), an important coactivator for p53-
Experimental proceduresmediated transcription and histone acetylation (Espinosa and
Emerson, 2001). Previous studies with ONYX-015 have used
Cell lines and culturing conditionsluciferase reporter assays to determine p53 activity in infected
Small airway epithelial cells (SAEC), mammary epithelial cells (MEC), and
cells. However, here we assessed the induction of endogenous hepatocytes from multiple donors were obtained from BioWhittaker, Inc.
p53 transcriptional targets, as recently it has become clear that and cultured as per themanufacturer’s recommendations. Primary cells were
synthetic p53-responsive reporters do not necessarily reflect rendered contact-inhibited by growing them to 100%confluency followed by
prolonged (14–18 days) incubation in complete medium. HCT-116 cells werethe regulation of the native promoters by chromatinmodification
cultured in McCoy’s medium with 10% fetal calf serum.(Espinosa and Emerson, 2001). Thus, it is intriguing to speculate
that E1A itself may perhaps compromise p53 function in ONYX-
Virus infections and quantification015 infection, although our analysis of ONYX-605, a mutant
All primary human cells were infected in predefined growth medium, in the
comprising an E1A-p300 binding mutant in combination with absence of antibiotics, with no alterations to growth factor components in
an E1B-55K deletion, suggests that this is not the case. Never- a low volume of medium for 2 hrs. HCT-116 cells were infected in a low
theless, E1A can modulate p300 in multiple ways. Conversely, volume of McCoy’s medium with 2% fetal bovine serum (FBS). Viruses were
quantified on 293/E4/pIX cells using an ELISA assay as described previouslyp53 induction alone may not be sufficient for p53 activity. A
(Johnson et al., 2002). Wild-type virus is WtD, a derivative of dl309 (whichsecond signal, perhaps through DNA damage-induced activa-
has a partial deletion in the E3 region), but identical to ONYX-015/dl1520tion of Chk1/Chk2, may be necessary (Shieh et al., 2000). Inter-
except that it includes E1B-55K. Cells were infected at multiplicity of infec-
estingly, another early viral protein, E4-ORF3, disrupts Mre11/ tions determined experimentally to be the minimum required to infect 100%
Nbs1 nuclear bodies (Stracker et al., 2002), an event that could of the cells. Thus, SAECs were infected at an moi of 10 and HCT-116 at an
conceivably abrogate Chk1/Chk2-mediated p53 activation fol- moi of 30.
lowingONYX-015 infection.We are currently attempting to iden-
Preparation of cell lysates and immunoblot analysistify this novel mechanism. Nevertheless, this study reveals that
Protein lysates were extracted and normalized and Western blotting per-loss of E1B-55K results in the induction, but not activation, of
formed as previously described (Johnson et al., 2002). The primary antibod-p53 during adenoviral replication. This has important implica-
ies used were against either E1A (M73 at 1:20, from E. Harlow, MGH Cancer
tions for understanding p53 inactivation in both tumor cells and Center), E1B-55K (1:20, mouse monoclonal 2A6), E1B-19K (1:500, Calbio-
adenovirus replication, and ultimately, for designing new p53- chem), E2A (1:20, B6-8, from T. Shenk, Princeton), E4orf3 (1:1,000, from G.
selective oncolytic viral strategies. Ketner, Johns Hopkins), E4orf6, 6/7 (1:10, RSA-3, from T. Shenk, Princeton;
or 1808-2 at 1:7,000, from P.E. Branton, McGill University), Fiber (1:1,000,This study also reveals a novel and unprecedented differ-
American Qualex), Ad5 late proteins (1:20,000, Access BioMedical), Cyclinence in RNA export between tumor and normal cells. We show
A (1:100, Neomarkers), Cyclin B (1:500, Neomarkers), p21 (1:100, Upstatethat this is the major determinant of ONYX-015 tumor-selective
Biotechnology), Mdm2 (1:1000, N20, Santa Cruz Biotechnology), activatedreplication. These data infer that late viral RNAs may share
caspase 3 (Pharmingen), PARP (1:1000, Transduction Labs), p53 (1:1000,
either a molecular resemblance, or export pathway, with RNAs DO-1, Santa Cruz Biotechnology), or -actin (1:250, Sigma). The p14ARF
important for cell growth or tumorigenesis.Major late viral RNAs, antibody was obtained from rabbits immunized with a human p14ARF peptide,
CPGRGAAGRARCLGPSARGPG, affinity-purified, and used at 1:1000.such as hexon and fiber, share a common 5UTR that facilitates
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Immunofluorescence itris Nussov, and Jay Sohal for technical advice and help with confocal
Cells were grown on chamber slides, fixed in 4% paraformaldehyde, and microscopy and FISH, and also William Forrest for help with statistical data
stored in PBS. Slides were washed 1 in PBS and blocked in 5% goat analysis. Real-time Q-PCR and sequencing was performed by the Genome
serum/0.1% fish skin gelatin/PBS for 20 min. Slides were subsequently Analysis Core with special thanks to Mamie Fung. Clodagh O’Shea was
blocked in 5% FBS/PBS for 20 min at room temperature (RT) followed by supported by a Leukemia Society of America fellowship. Frank McCormick
incubation with primary antibodies for 1 hr at RT. Primary antibodies used and Bridget Bagus were supported, in part, by ONYX Pharmaceuticals and
were rat anti-E1B-55K (Calbiochem) and mouse anti-p53 (DO-1, Santa Cruz UC Discovery grant bio-02-10242, and Frank McCormick is a shareholder
Biotechnology). Slides were washed three times in PBS and then incubated in ONYX Pharmaceuticals.
with either Alexa-532 anti-rat or Alexa-488 anti-mouse antibodies (Molecular
Probes) for 1 hr at RT. Slides were then washed three times in PBS and
nuclei counterstained with Hoechst. Slides were mounted in Dako fluores-
cent mounting media and analyzed by fluorescent microscopy. Received: May 12, 2004
Revised: October 27, 2004
Flow cytometry analysis Accepted: November 17, 2004
Cell cycle analysis was performed as described previously (Johnson et al., Published: December 20, 2004
2002). For Annexin V/PI staining, following trypsinization and neutralization,
cells were resuspended in 1 binding buffer (10 mM Hepes/NaOH [pH 7.4], References
140 mM NaCl, 2.4 mMMgCl2) and staining carried out as per manufacturer’s
instructions (Pharmingen).
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